Transmedics Group Inc (NASDAQ:TMDX)’s traded shares stood at 1.4 million during the last session, with the company’s beta value hitting 2.12. At the close of trading, the stock’s price was $73.76, to imply an increase of 1.04% or $0.76 in intraday trading. The TMDX share’s 52-week high remains $177.37, putting it -140.47% down since that peak but still an impressive 25.43% since price per share fell to its 52-week low of $55.00.
Analysts have given a consensus recommendation of Buy for Transmedics Group Inc (TMDX), translating to a mean rating of 1.70. Of 7 analyst(s) looking at the stock, 0 analyst(s) give TMDX a Sell rating. 0 of those analysts rate the stock as Overweight while 2 advise Hold as 5 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at 0.15.
Transmedics Group Inc (NASDAQ:TMDX) trade information
After registering a 1.04% upside in the last session, Transmedics Group Inc (TMDX) has traded red over the past five days. The 5-day price performance for the stock is -7.13%, and 20.78% over 30 days. With these gigs, the year-to-date price performance is 18.30%.
The extremes give us $90 and $125 for target low and target high price respectively. As such, TMDX has been trading -69.47% off suggested target high and -22.02% from its likely low.
Transmedics Group Inc (TMDX) estimates and forecasts
The rating firms project that company’s revenue will grow 77.76% compared to the previous financial year.
Revenue forecast for the current quarter as set by 8 analysts is 109.49M. Meanwhile, for the current quarter, a total of 6 analyst(s) estimate revenue growth to 119.4M.Earnings reports from the last fiscal year show that sales brought in 81.17M and 96.85M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 34.88% before jumping 23.28% in the following quarter.
TMDX Dividends
Transmedics Group Inc has its next earnings report out in March. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Transmedics Group Inc (NASDAQ:TMDX)’s Major holders
The next major institution holding the largest number of shares is BLACKROCK INC. with 2.65 million shares, or about 8.0755% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $398.47 million.
